• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

0.5986 +0.0386 (+6.89%)
Streaming Delayed Price Updated: 11:33 AM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 473,419
Open 0.5500
Bid (Size) 0.5973 (13)
Ask (Size) 0.5992 (1)
Prev. Close 0.5600
Today's Range 0.5450 - 0.6000
52wk Range 0.4300 - 3.880
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeoVax Leadership to Participate in Key European Meetings to Advance Partnering Discussions
October 13, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Leadership to Participate in Key European Meetings to Advance Partnering Discussions
October 13, 2025
Via TheNewswire.com

Performance

YTD
-75.9%
-75.9%
1 Month
-12.8%
-12.8%
3 Month
-12.6%
-12.6%
6 Month
-44.1%
-44.1%
1 Year
-70.2%
-70.2%

More News

Read More
GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025
October 09, 2025
Via NewMediaWire
GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025
October 09, 2025
Via TheNewswire.com
GeoVax to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
October 07, 2025
Via TheNewswire.com
GeoVax to Sponsor the 2025 Dr. David Satcher Global Health Equity Summit
October 01, 2025
Via TheNewswire.com
GeoVax Expands Gedeptin(R) Development to Additional Solid Tumor Indications
September 24, 2025
Via TheNewswire.com
GeoVax Reaffirms Commitment to Evidence-Based Vaccine Safety and Development of GEO-CM04S1 for Vulnerable Populations
September 22, 2025
Via TheNewswire.com
GeoVax to Present CM04S1 Clinical Progress at the Emerging Growth Conference
September 18, 2025
Via TheNewswire.com
GeoVax to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
October 07, 2025
Via NewMediaWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 02, 2025
Via Benzinga
GeoVax to Sponsor the 2025 Dr. David Satcher Global Health Equity Summit
October 01, 2025
Via NewMediaWire
Wondering what's happening in today's after-hours session?
September 30, 2025
Via Chartmill
Here are the top movers in Tuesday's session.
September 30, 2025
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 30, 2025
Via Benzinga
Tuesday's session: gap up and gap down stocks
September 30, 2025
Via Chartmill
GeoVax Labs Announces $2.5 Million Registered Direct Offering
September 30, 2025
Via NewMediaWire
Topics Regulatory Compliance
GeoVax Labs Announces $2.5 Million Registered Direct Offering
September 30, 2025
Via TheNewswire.com
Topics Regulatory Compliance
GeoVax Comments on U.S. America First Global Health Strategy and Highlights Company's Role in Advancing American Innovation, Pandemic Preparedness, and Global Health Security
September 29, 2025
Via NewMediaWire
Topics Economy
GeoVax Comments on U.S. America First Global Health Strategy and Highlights Company's Role in Advancing American Innovation, Pandemic Preparedness, and Global Health Security
September 29, 2025
Via TheNewswire.com
Topics Economy
GeoVax Expands Gedeptin(R) Development to Additional Solid Tumor Indications
September 24, 2025
Via NewMediaWire
GeoVax Reaffirms Commitment to Evidence-Based Vaccine Safety and Development of GEO-CM04S1 for Vulnerable Populations
September 22, 2025
Via NewMediaWire
GeoVax to Present CM04S1 Clinical Progress at the Emerging Growth Conference
September 18, 2025
Via NewMediaWire
GeoVax Showcases Positive Phase 2 Data for GEO-CM04S1 in CLL Patients at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Conference
September 15, 2025
Via NewMediaWire
GeoVax Showcases Positive Phase 2 Data for GEO-CM04S1 in CLL Patients at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Conference
September 15, 2025
Via TheNewswire.com

Frequently Asked Questions

Is GeoVax Labs, Inc. - Common Stock publicly traded?
Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
What exchange does GeoVax Labs, Inc. - Common Stock trade on?
GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
What is the current price of GeoVax Labs, Inc. - Common Stock?
The current price of GeoVax Labs, Inc. - Common Stock is 0.5986
When was GeoVax Labs, Inc. - Common Stock last traded?
The last trade of GeoVax Labs, Inc. - Common Stock was at 10/14/25 11:33 AM ET
What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
The market capitalization of GeoVax Labs, Inc. - Common Stock is 1.30M
How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
GeoVax Labs, Inc. - Common Stock has 1M shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.61
+1.97 (0.81%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap